Protagonist Therapeutics (PTGX) Q1 2023 Earnings

16MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.93
-0.82
-0.7
-0.59

Details

Expected EPS
-0.73
Actual EPS
-0.67
Surprise EPS
0.06
Surprise Percent
+8.22%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.67 per share for Q1 2023.

0 Comments

Share your thoughts